Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suiping Liu

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Theranostics|June 7, 2023
Nanoblock-mediated selective oncolytic polypeptide therapy for triple-negative breast cancerCuiyu Zhong, Jie Li, Suiping Liu, et al.
Immunotargets and Therapy|June 3, 2026
Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple MyelomaSuiping Liu, Jieying Wu, Jiayu Liu, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Theranostics|June 7, 2023
Nanoblock-mediated selective oncolytic polypeptide therapy for triple-negative breast cancerCuiyu Zhong, Jie Li, Suiping Liu, et al.
Immunotargets and Therapy|June 3, 2026
Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple MyelomaSuiping Liu, Jieying Wu, Jiayu Liu, et al.
Pageof 1